Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TIGIT
Biotech
ESMO: iTeos-GSK's TIGIT star shows meaningful improvement
iTeos and GSK are launching their spaceship into another galaxy, touting phase 2 findings that prompted the late-stage GALAXIES Lung-301 trial.
Gabrielle Masson
Sep 14, 2024 2:30am
Merck stops phase 3 TIGIT trial in lung cancer for futility
Aug 8, 2024 7:49am
BMS ditches TIGIT, ending $200M bet on Agenus bispecific
Aug 5, 2024 9:17am
Roche stops pivotal TIGIT trial as Keytruda lands knockout blow
Jul 4, 2024 5:10am
Merck halts phase 3 melanoma TIGIT trial due to discontinuations
May 13, 2024 8:39am
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Feb 1, 2024 11:30am
